Jim Nelson

Intellectual Property

About Jim Nelson

Schwegman, Lundberg & Woessner

121 S 8th St #1600 Minneapolis, Minnesota

jnelson@slwip.com

(612) 373-6939

View Lawyer's Website

Topics Addressed by This Lawyer

About the Intellectual Property Law Firms

Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals

BioSimilars

Merrifield Synthesis

Biologics Price Competition and Innovation Act

Demonstrating BioSimilarity Under U.S. Law

Approvals of BioSimilars in Europe

Biologics vs Small Molecules

How to Navigate BioSimilar Challenges

FDA Guidelines for Demonstrating Biosimilarity

Litigation and BioSimilar Patenting

Naming Problems with BioSimilars

BioSimilar Patenting Litigation Involving Large Amounts of Money

Impact of US Hatch Waxman Act 1984

What is a BioSimilar?

Why Are Biologicals so Important?

Claim Maps and BioSimilars

Are BioSimilars Being Approved in the US?

Sponsor

What is a BioSimilar Product Under US Law?

Who Determines Substitution Factors?

Meet the Intellectual Property Lawyers

Technical Background

Rewards of the Practice

Experience